Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 3 , Pages 327-337 , June 2010

Magnesium in obstetrics

  • M.F.M. James, MBChB, PhD, FRCA (Professor and Head)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +27 21 406 6143; Fax: +27 21 447 5206.

References 

  1. Saris NE, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294:1–26
  2. DeJorge FB, Delascio D, de UlhoaCint AB, Antunes ML. Magnesium concentration in the blood serum of normal pregnant women. Obstet Gynecol. 1965;25:253–254
  3. Spatling L, Disch G, Classen H. Magnesium in pregnant women and the newborn. Magnes Res. 1989;2:271–280
  4. Durlach J. New data on the importance of gestational Mg deficiency. J Am Coll Nutr. 2004;23:694S–700S
  5. Hantoushzadeh S, Jafarabadi M, Khazardoust S. Serum magnesium levels, muscle cramps, and preterm labor. Int J Gynaecol Obstet. 2007;98:153–154
  6. Venu L, Padmavathi IJ, Kishore YD, et al. Long-term effects of maternal magnesium restriction on adiposity and insulin resistance in rat pups. Obesity (Silver Spring). 2008;16:1270–1276
  7. Weaver K. Pregnancy-induced hypertension and low birth weight in magnesium-deficient ewes. Magnesium. 1986;5:191–200
  8. Spatling L, Spatling G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol. 1988;95:120–125
  9. Kisters K, Barenbrock M, Louwen F, et al. Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia. Am J Hypertens. 2000;13:765–769
  10. Standley CA, Whitty JE, Mason BA, Cotton DB. Serum ionized magnesium levels in normal and preeclamptic gestation. Obstet Gynecol. 1997;89:24–27
  11. Resnick LM, Barbagallo M, Bardicef M, et al. Cellular-free magnesium depletion in brain and muscle of normal and preeclamptic pregnancy: a nuclear magnetic resonance spectroscopic study. Hypertension. 2004;44:322–326
  12. Seydoux J, Girardin E, Paunier L, Beguin F. Serum and intracellular magnesium during normal pregnancy and in patients with pre-eclampsia. Br J Obstet Gynaecol. 1992;99:207–211
  13. Fong J, Gurewitsch ED, Volpe L, et al. Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia. Obstet Gynecol. 1995;85:444–448
  14. Barbagallo M, Dominguez LJ, Resnick LM. Magnesium metabolism in hypertension and type 2 diabetes mellitus. Am J Ther. 2007;14:375–385
  15. Lazard EM. A preliminary report on the intravenous use of magnesium sulphate in puerperal eclampsia. Am J Obstet Gynecol. 1925;9:178–188
  16. Pritchard JA. The use of the magnesium ion in the management of eclamptic toxaemias. Surgery, Gynaecology, Obstetrics. 1955;100:131–140
  17. Steer CM, Petrie RH. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol. 1977;129:1–4
  18. Elliott JP. Magnesium sulfate as a tocolytic agent. Am J Obstet Gynecol. 1983;147:277–284
  19. Bardgett ME, Schultheis PJ, McGill DL, et al. Magnesium deficiency impairs fear conditioning in mice. Brain Res. 2005;1038:100–106
  20. Mueksch JN, Stevens WA. Undiagnosed myasthenia gravis masquerading as eclampsia. Int J Obstet Anesth. 2007;16:379–382
  21. Catanzarite V, Gambling D, Bird LM, et al. Respiratory compromise after MgSO4 therapy for preterm labor in a woman with myotonic dystrophy: a case report. J Reprod Med. 2008;53:220–222
  22. Ramanathan J, Sibai BM, Pillai R, Angel JJ. Neuromuscular transmission studies in preeclamptic women receiving magnesium sulfate. Am J Obstet Gynecol. 1988;158:40–46
  23. Herpolsheimer A, Brady K, Yancey MK, et al. Pulmonary function of preeclamptic women receiving intravenous magnesium sulfate seizure prophylaxis. Obstet Gynecol. 1991;78:241–244
  24. Bilgin T, Cengiz C, Ozan H. Alterations in respiratory functions during magnesium sulfate infusion in severe preeclampsia and eclampsia. Int J Gynaecol Obstet. 1994;45:59–60
  25. Altura BM, Altura BT, Carella A, et al. Mg2+ -Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol. 1987;65:729–745
  26. James MFM, Cork RC, Dennett JE. Cardiovascular effects of magnesium sulfate in the baboon. Magnesium. 1987;6:314–324
  27. Nakayama T, Nakayama H, Miyamoto M, Hamlin RL. Hemodynamic and electrocardiographic effects of magnesium sulfate in healthy dogs. J Vet Intern Med. 1999;13:485–490
  28. Standley CA, Batia L, Yueh G. Magnesium sulfate effectively reduces blood pressure in an animal model of preeclampsia. J Matern Fetal Neonatal Med. 2006;19:171–176
  29. Douglas MJ, Ward ME. Current pharmacology and the obstetric anesthesiologist. Int Anesthesiol Clin. 1994;32:1–10
  30. Cotton DB, Gonik B, Karen F, Dornan RN. Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate. American Journal of Obstetrics and Gynaecology. 1984;148:162–165
  31. Fletcher SJ, Parr MJ. Life-threatening magnesium toxicity [letter]. Intensive Care Med. 2000;26:257
  32. Scardo JA, Hogg BB, Newman RB. Favorable hemodynamic effects of magnesium sulfate in preeclampsia. Am J Obstet Gynecol. 1995;173:1249–1253
  33. Chestnut DH, Thompson CS, McLaughlin GL, Weiner CP. Does the intravenous infusion of ritodrine or magnesium sulfate alter the hemodynamic response to hemorrhage in gravid ewes?. Am J Obstet Gynecol. 1988;159:1467–1473
  34. Kurtzman JL, Thorp JM, Spielman FJ, et al. Do nifedipine and verapamil potentiate the cardiac toxicity of magnesium sulfate?. Am J Perinatol. 1993;10:450–452
  35. Davis WB, Wells SR, Kuller JA, Thorp JMJ. Analysis of the risks associated with calcium channel blockade: implications for the obstetrician-gynecologist. [Review] [18 refs]. Obstetrical & Gynecological Survey. 1997;52:198–201
  36. Magee LA, Miremadi S, Li J, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol. 2005;193:153–163
  37. Vercauteren M, Palit S, Soetens F, et al. Anaesthesiological considerations on tocolytic and uterotonic therapy in obstetrics. Acta Anaesthesiol Scand. 2009;
  38. Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877–1890
  39. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol. 2005;105:402–410
  40. Duley L. Magnesium sulphate in eclampsia. Eclampsia Trial Collaborative Group. Lancet. 1998;352:67–68
  41. Duley L, Henderson SD. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2000;CD000128
  42. Duley L, Henderson SD. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2000;CD000127
  43. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2003;CD000025
  44. Cotton DB, Hallak M, Janusz C, et al. Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures. Am J Obstet Gynecol. 1993;168:974–978
  45. Mason BA, Standley CA, Irtenkauf SM, et al. Magnesium is more efficacious than phenytoin in reducing N-methyl-D-aspartate seizures in rats. Am J Obstet Gynecol. 1994;171:999–1002
  46. Sadeh M. Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. Stroke. 1989;20:1273–1275
  47. Belfort MA, Moise KJJ. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol. 1992;167:661–666
  48. Naidu S, Payne AJ, Moodley J, et al. Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial doppler ultrasound. Br J Obstet Gynaecol. 1996;103:111–116
  49. Altura BT, Altura BM. Interactions of Mg and K on cerebral vessels - aspects in view of stroke. Review of present status and new findings. Magnesium. 1984;3:195–211
  50. Ludbrook GL, James MF, Upton RN. The effect of magnesium sulfate on cerebral blood flow velocity, cardiovascular variables, and arterial carbon dioxide tension in awake sheep. J Neurosurg Anesthesiol. 1999;11:96–101
  51. Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke. 2009;40:1169–1175
  52. Belfort M, Allred J, Dildy G. Magnesium sulfate decreases cerebral perfusion pressure in preeclampsia. Hypertens Pregnancy. 2008;27:315–327
  53. James MF, Neil G. Effect of magnesium on coagulation as measured by thrombelastography. Br J Anaesth. 1995;74:92–94
  54. Assaley J, Baron JM, Cibils LA. Effects of magnesium sulfate infusion upon clotting parameters in patients with pre-eclampsia. Journal of Perinatal Medicine. 1998;26:115–119
  55. Ravn HB, Lassen JF, Bergenhem N, Kristensen AT. Intravenous magnesium does not influence the activity of the coagulation cascade. Blood Coagul Fibrinolysis. 2001;12:223–228
  56. Hollander DI, Nagey DA, Pupkin MJ. Magnesium sulfate and ritodrine hydrochloride: a randomized comparison. Am J Obstet Gynecol. 1987;156:631–637
  57. Chau AC, Gabert HA, Miller JM. A prospective comparison of terbutaline and magnesium for tocolysis. Obstet Gynecol. 1992;80:847–851
  58. Grimes DA, Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol. 2006;108:986–989
  59. Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med. 2007;357:477–487
  60. Crowther CA, Moore V. Magnesium for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2000;CD000940
  61. Which anticonvulsant for women with eclampsia? evidence from the collaborative eclampsia trial. Lancet. 1995;345:1455–1463
  62. Leveno KJ, Alexander JM, McIntire DD, Lucas MJ. Does magnesium sulfate given for prevention of eclampsia affect the outcome of labor?. Am J Obstet Gynecol. 1998;178:707–712
  63. Szal SE, Croughan-Minihane MS, Kilpatrick SJ. Effect of magnesium prophylaxis and preeclampsia on the duration of labor. Am J Obstet Gynecol. 1999;180:1475–1479
  64. Atkinson MW, Guinn D, Owen J, Hauth JC. Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension?. Am J Obstet Gynecol. 1995;173:1219–1222
  65. Riaz M, Porat R, Brodsky NL, Hurt H. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study. J Perinatol. 1998;18:449–454
  66. Rantonen T, Kaapa P, Jalonen J, et al. Antenatal magnesium sulphate exposure is associated with prolonged parathyroid hormone suppression in preterm neonates. Acta Paediatr. 2001;90:278–281
  67. Guzman ER, Conley M, Stewart R, et al. Phenytoin and magnesium sulfate effects on fetal heart rate tracings assessed by computer analysis. Obstet Gynecol. 1993;82:375–379
  68. Atkinson MW, Belfort MA, Saade GR, Moise-Kj J. The relation between magnesium sulfate therapy and fetal heart rate variability. Obstet Gynecol. 1994;83:967–970
  69. Maulik D, Mishra OP, Delivoria-Papadopoulos M. Effect of post-hypoxic MgSO(4) administration in utero on Ca(2+)-influx and Ca(2+)/calmodulin kinase IV activity in cortical neuronal nuclei. Neurosci Lett. 2005;386:127–132
  70. FineSmith RB, Roche K, Yellin PB, et al. Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants. Am J Perinatol. 1997;14:303–307
  71. Canterino JC, Verma UL, Visintainer PF, et al. Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage. Obstet Gynecol. 1999;93:396–402
  72. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?. Pediatrics. 1995;95:263–269
  73. Grether JK, Hoogstrate J, Selvin S, Nelson KB. Magnesium sulfate tocolysis and risk of neonatal death [see comments]. Am J Obstet Gynecol. 1998;178:1–6
  74. Schendel DE, Berg CJ, Yeargin-Allsopp M, et al. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years [see comments]. JAMA. 1996;276:1805–1810
  75. Kimberlin DF, Hauth JC, Goldenberg RL, et al. The effect of maternal magnesium sulfate treatment on neonatal morbidity in < or = 1000-gram infants. Am J Perinatol. 1998;15:635–641
  76. Scudiero R, Khoshnood B, Pryde PG, et al. Perinatal death and tocolytic magnesium sulfate. Obstet Gynecol. 2000;96:178–182
  77. Herschel M, Mittendorf R. Tocolytic magnesium sulfate toxicity and unexpected neonatal death. J Perinatol. 2001;21:261–262
  78. Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol. 2002;186:1111–1118
  79. Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009;200:595–609
  80. Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;CD004661
  81. Smith GC, McEwan HP. Use of magnesium sulphate in Scottish obstetric units. Br J Obstet Gynaecol. 1997;104:115–116
  82. Alexander JM, McIntire DD, Leveno KJ, Cunningham FG. Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstet Gynecol. 2006;108:826–832
  83. Scott JR. Preventing eclampsia: magnesium sulfate regimens revisited. Obstet Gynecol. 2006;108:824–825
  84. Ehrenberg HM, Mercer BM. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol. 2006;108:833–838
  85. Haas DM, Imperiale TF, Kirkpatrick PR, et al. Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol. 2009;113:585–594
  86. Lewis DF. Magnesium sulfate: the first-line tocolytic. Obstet Gynecol Clin North Am. 2005;32:485–500
  87. Elliott JP, Lewis DF, Morrison JC, Garite TJ. In defense of magnesium sulfate. Obstet Gynecol. 2009;113:1341–1348
  88. Fox NS, Gelber SE, Kalish RB, Chasen ST. Contemporary practice patterns and beliefs regarding tocolysis among U.S. Maternal-fetal medicine specialists. Obstet Gynecol. 2008;112:42–47
  89. Newsome LR, Bramwell RS, Curling PE. Severe preeclampsia: hemodynamic effects of lumbar epidural anesthesia. Anesth Analg. 1986;65:31–36
  90. Vincent RD, Chestnut DH, Sipes SL, et al. Magnesium sulfate decreases maternal blood pressure but not uterine blood flow during epidural anesthesia in gravid ewes. Anesthesiology. 1991;74:77–82
  91. Sipes SL, Chestnut DH, Vincent RDJ, et al. Which vasopressor should be used to treat hypotension during magnesium sulfate infusion and epidural anesthesia?. Anesthesiology. 1992;77:101–108
  92. James MF, Huddle KR, Owen AD, van der Veen BW. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma in pregnancy. Can J Anaesth. 1988;35:178–182
  93. Hamilton A. Anaesthesia for phaeochromocytoma in pregnancy. Can J Anaesth. 1997;44:654–657
  94. Bullough A, Karadia S, Watters M. Phaeochromocytoma: an unusual cause of hypertension in pregnancy. Anaesthesia. 2001;56:43–46

PII: S1521-6934(09)00142-4

doi: 10.1016/j.bpobgyn.2009.11.004

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 3 , Pages 327-337 , June 2010

Article Tools